Yamamoto S et al. |
Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production. |
2017 |
Biochem. Biophys. Res. Commun. |
pmid:27998764
|
Santos MA et al. |
Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection. |
2017 |
Am. J. Med. |
pmid:27984010
|
Hiroi S et al. |
Impact of health insurance coverage for gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. |
2017 |
BMJ Open |
pmid:28760790
|
Jenkins H et al. |
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study. |
2017 |
Clin Drug Investig |
pmid:27928738
|
Takemoto Y et al. |
Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent Host. |
2017 |
Intern. Med. |
pmid:28717096
|
Alba C et al. |
Antibiotic resistance in Helicobacter pylori. |
2017 |
Curr. Opin. Infect. Dis. |
pmid:28704226
|
Mishima E et al. |
Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole. |
2017 |
Intern. Med. |
pmid:28674358
|
Sun W et al. |
Synergistic drug combination effectively blocks Ebola virus infection. |
2017 |
Antiviral Res. |
pmid:27890675
|
Shimoyama T et al. |
Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens. |
2017 |
Intern. Med. |
pmid:28674348
|
Ustundag GH et al. |
The Effects of Synbiotic " B94 plus Inulin" Addition on Standard Triple Therapy of Eradication in Children. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28656129
|
Peng X et al. |
Gastric Juice-Based Real-Time PCR for Tailored Treatment: A Practical Approach. |
2017 |
Int J Med Sci |
pmid:28638276
|
Stieler Stewart AL et al. |
Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals. |
2017 |
Equine Vet. J. |
pmid:28238211
|
Tsugawa K et al. |
Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells. |
2017 |
Clin. Exp. Nephrol. |
pmid:27614743
|
Bewick J et al. |
The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis. |
2017 |
Clin Otolaryngol |
pmid:27223120
|
Legendre T et al. |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy]. |
2017 |
Encephale |
pmid:27178256
|
Choi HS et al. |
Peritoneal Dialysis-Related Peritonitis Caused by Microbacterium paraoxydans. |
2017 |
Jpn. J. Infect. Dis. |
pmid:27169951
|
Abadi ATB |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. |
2017 |
World J. Gastroenterol. |
pmid:29085187
|
Pastukh N et al. |
GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones. |
2017 |
Helicobacter |
pmid:29058343
|
Tognetti L et al. |
Bullous impetigo during interstitial pneumonitis. |
2017 |
G Ital Dermatol Venereol |
pmid:29050448
|
Van der Paardt AL et al. |
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. |
2017 |
Eur. Respir. J. |
pmid:28331034
|
Souto Filho JTD et al. |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection. |
2017 |
Ann. Hematol. |
pmid:28315923
|
Antonakos N et al. |
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome. |
2017 |
Crit Care |
pmid:28274246
|
Koratala A et al. |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement. |
2017 |
Blood Purif. |
pmid:28268216
|
McCallum GB et al. |
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. |
2017 |
Cochrane Database Syst Rev |
pmid:28828759
|
de Ãvila BE et al. |
Micromotor-enabled active drug delivery for in vivo treatment of stomach infection. |
2017 |
Nat Commun |
pmid:28814725
|
Zhang D et al. |
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. |
2017 |
Medicine (Baltimore) |
pmid:28796053
|
Fraser AG |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776748
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
Makihara K et al. |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. |
2017 |
Cancer Chemother. Pharmacol. |
pmid:28711984
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Iwayama K et al. |
Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression. |
2017 |
BMC Pharmacol Toxicol |
pmid:28235416
|
Komiya K et al. |
Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. |
2017 |
Respir. Res. |
pmid:28219384
|
Sakurai K et al. |
Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy. |
2017 |
World J. Gastroenterol. |
pmid:28216974
|
Awan S et al. |
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study. |
2017 |
Lung Cancer |
pmid:28213005
|
Su J et al. |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial. |
2017 |
Medicine (Baltimore) |
pmid:28207505
|
Branquinho D et al. |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? |
2017 |
BMC Gastroenterol |
pmid:28202013
|
Huang CC et al. |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. |
2018 |
J Microbiol Immunol Infect |
pmid:28705770
|
Kelly C et al. |
Macrolide antibiotics for bronchiectasis. |
2018 |
Cochrane Database Syst Rev |
pmid:29543980
|
Mégraud F |
Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:30308190
|
Mieras LF et al. |
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+. |
2018 |
BMC Infect. Dis. |
pmid:30290790
|
Liou JM et al. |
Toward population specific and personalized treatment of Helicobacter pylori infection. |
2018 |
J. Biomed. Sci. |
pmid:30285834
|
Liu HY et al. |
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. |
2018 |
J Refract Surg |
pmid:30199569
|
Kabakambira JD et al. |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial. |
2018 |
BMC Gastroenterol |
pmid:30165823
|
Yotsu RR et al. |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). |
2018 |
Cochrane Database Syst Rev |
pmid:30136733
|
Tang D et al. |
[Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment]. |
2018 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:30124214
|
Byeon JY et al. |
Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem. |
2018 |
Arch. Pharm. Res. |
pmid:30117082
|
Park CG et al. |
Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study. |
2018 |
Medicine (Baltimore) |
pmid:30113472
|
Morgene MF et al. |
HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics. |
2018 |
Virology |
pmid:30077071
|
Shinozaki S et al. |
Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen. |
2018 |
Kaohsiung J. Med. Sci. |
pmid:30041763
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Hamza D et al. |
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance. |
2018 |
Microb. Pathog. |
pmid:30031039
|
Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Abu-Khalaf N et al. |
The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation. |
2018 |
Sensors (Basel) |
pmid:29401675
|
Chai KY et al. |
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report. |
2018 |
J Med Case Rep |
pmid:29743095
|
Strouvalis I et al. |
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. |
2018 |
Respirology |
pmid:29741298
|
Long X et al. |
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance. |
2018 |
Helicobacter |
pmid:29696736
|
Fiorini G et al. |
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. |
2018 |
Scand. J. Gastroenterol. |
pmid:29688095
|
Matta AJ et al. |
Punctual mutations in gene of clarithromycin-resistant in Colombian populations. |
2018 |
World J. Gastroenterol. |
pmid:29662291
|
RodrÃguez-Sevilla G et al. |
Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa. |
2018 |
Pathog Dis |
pmid:29648588
|
Namkoong H et al. |
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. |
2018 |
PLoS Pathog. |
pmid:29621339
|
Berende A et al. |
Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease. |
2018 |
PLoS ONE |
pmid:29608590
|
Mabe K et al. |
Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan. |
2018 |
J. Infect. Chemother. |
pmid:29605555
|
Chen SA et al. |
HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29575644
|
van Dyk M et al. |
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29572563
|
Chen J et al. |
Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29562911
|
RodrÃguez-Sevilla G et al. |
Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. |
2018 |
Int. J. Med. Microbiol. |
pmid:29555180
|
Leung WK et al. |
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. |
2018 |
Gastroenterology |
pmid:29550592
|
Kusuki M et al. |
Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29550059
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Reisfeld L et al. |
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis. |
2018 |
Dis. Aquat. Org. |
pmid:29516862
|
Wang YH et al. |
A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29405526
|
Tso S et al. |
Clarithromycin as a steroid sparing agent for the management of infantile bullous pemphigoid. |
2018 |
BMJ Case Rep |
pmid:29374651
|
Sahara S et al. |
Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. |
2018 |
Digestion |
pmid:29310119
|
Aderemi AO et al. |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics. |
2018 |
Aquat. Toxicol. |
pmid:30125766
|
Sue S et al. |
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial. |
2018 |
Helicobacter |
pmid:29271026
|
Nakase K et al. |
Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes. |
2018 |
J. Dermatol. |
pmid:29235673
|
Cho EH et al. |
Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. |
2018 |
J. Infect. Chemother. |
pmid:29223615
|
Compain F et al. |
In vitro activity of tedizolid against the Mycobacterium abscessus complex. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29217419
|
Li H et al. |
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study. |
2018 |
Scand. J. Gastroenterol. |
pmid:29214879
|
Jung JH et al. |
Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Infection. |
2018 |
Gut Liver |
pmid:29212313
|
Deng J et al. |
Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial. |
2018 |
Int Forum Allergy Rhinol |
pmid:29195025
|
Beer-Davidson G et al. |
Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction. |
2018 |
Helicobacter |
pmid:29181860
|
Muñoz-Gómez P et al. |
Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens. |
2018 |
Helicobacter |
pmid:29178562
|
Zagari RM et al. |
Treatment of Helicobacter pylori infection: A clinical practice update. |
2018 |
Eur. J. Clin. Invest. |
pmid:29144559
|
Liu DS et al. |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. |
2018 |
Clin. Microbiol. Infect. |
pmid:29138101
|
Marsousi N et al. |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software. |
2018 |
Biopharm Drug Dispos |
pmid:28960401
|
De Lorenzi G et al. |
Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo). |
2018 |
Top Companion Anim Med |
pmid:30502861
|
McNicholl AG et al. |
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial. |
2018 |
Helicobacter |
pmid:30141228
|
Silva GM et al. |
Helicobacter pylori antimicrobial resistance in a pediatric population. |
2018 |
Helicobacter |
pmid:30091503
|
Popovic V et al. |
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome. |
2018 |
Folia Microbiol. (Praha) |
pmid:28913757
|
Mahachai V et al. |
Helicobacter pylori management in ASEAN: The Bangkok consensus report. |
2018 |
J. Gastroenterol. Hepatol. |
pmid:28762251
|
Bilgilier C et al. |
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. |
2018 |
Clin. Microbiol. Infect. |
pmid:28669844
|
Barros S et al. |
Cat Scratch Disease: Not a Benign Condition. |
2018 |
Ocul. Immunol. Inflamm. |
pmid:28665750
|
Hosono Y et al. |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. |
2018 |
J. Infect. Chemother. |
pmid:29361415
|
Yoshida S et al. |
Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan. |
2018 |
J. Med. Microbiol. |
pmid:29227218
|
Alenezi A et al. |
Controlled release of clarithromycin from PLGA microspheres enhances bone regeneration in rabbit calvaria defects. |
2018 |
J. Biomed. Mater. Res. Part B Appl. Biomater. |
pmid:28067984
|
Choi IJ et al. |
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. |
2018 |
N. Engl. J. Med. |
pmid:29562147
|
Ribaldone DG et al. |
Helicobacter pylori eradication: poor medical compliance from East to West of the world. |
2018 |
Scand. J. Gastroenterol. |
pmid:29383955
|
Suzuki K et al. |
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. |
2018 |
Respir Investig |
pmid:29325687
|